Blog | Oncotarget.net

Oncotarget News

New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity

January 13, 2026

Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike may cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53.”BUFFALO, NY - January... read more

Oncotarget

Evaluation of Cancer Reports Following COVID-19 Vaccination and Infection

January 8, 2026

The collective world-wide evidence from 2020–2025 underscores a biologically plausible connection between COVID-19 vaccination and cancer.”BUFFALO, NY - January 8, 2026 – A new review was published in Oncotarget (Volume... read more

Oncotarget

Colorectal Cancer Survival Predicted by AI Using Clinical and Molecular Features

December 17, 2025

The clinical and biological features proposed here in conjunction with ML can improve the interpretation of CRC mechanisms and predict patient survival.”BUFFALO, NY - December 17, 2025 – A new research... read more

Oncotarget

Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors

November 18, 2025

The anticancer properties of bifidobacterium may also stem from its ability to detoxify carcinogens and transform dietary elements.”BUFFALO, NY - November 18, 2025 – A new review was published in Oncotarget (... read more

Oncotarget

Clinical Trial Participants Call for More Inclusive, Patient-Centered Cancer Research

November 17, 2025

By embracing transparency, inclusivity, and patient advocacy, we can transform clinical trials into a true partnership between medical research and the individuals it seeks to serve.”BUFFALO, NY - November 17,... read more

Oncotarget

Lower LRIG1 Expression Linked to Aggressive Gliomas

November 12, 2025

Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas.”BUFFALO, NY - November 12, 2025 – A new research paper was published... read more